Ausgabe 18/2012
Inhalt (11 Artikel)
Can a New Ultra-Long-Acting Insulin Analogue Improve Patient Care? Investigating the Potential Role of Insulin Degludec
Jennifer D. Robinson, Joshua J. Neumiller, R. Keith Campbell
US Food and Drug Administration’s Risk Evaluation and Mitigation Strategy for Extended-Release and Long-Acting Opioids
Sebastiano Mercadante, David Craig, Antonello Giarratano
Diagnosis and Therapeutic Management of Extra-Intestinal Manifestations of Inflammatory Bowel Disease
Guru Trikudanathan, Preethi G. K. Venkatesh, Udayakumar Navaneethan
Primary Prevention of Major Cardiovascular and Cerebrovascular Events with Statins in Diabetic Patients
Folgerdiena M. de Vries, Petra Denig, Koen B. Pouwels, Maarten J. Postma, Eelko Hak
Meningococcal Quadrivalent (Serogroups A, C, W135 and Y) Tetanus Toxoid Conjugate Vaccine (Nimenrix™)
Jamie D. Croxtall, Sohita Dhillon